CN104817525A - Fluorine-containing 2,3-dihydrobenzofuran-3-alcoholic compound and preparation method thereof - Google Patents

Fluorine-containing 2,3-dihydrobenzofuran-3-alcoholic compound and preparation method thereof Download PDF

Info

Publication number
CN104817525A
CN104817525A CN201510171596.6A CN201510171596A CN104817525A CN 104817525 A CN104817525 A CN 104817525A CN 201510171596 A CN201510171596 A CN 201510171596A CN 104817525 A CN104817525 A CN 104817525A
Authority
CN
China
Prior art keywords
fluorine
dihydrobenzofuranes
alcohol
preparation
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510171596.6A
Other languages
Chinese (zh)
Other versions
CN104817525B (en
Inventor
华明清
王巍
张岐
黄燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu University
Original Assignee
Jiangsu University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu University filed Critical Jiangsu University
Priority to CN201510171596.6A priority Critical patent/CN104817525B/en
Publication of CN104817525A publication Critical patent/CN104817525A/en
Application granted granted Critical
Publication of CN104817525B publication Critical patent/CN104817525B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the technical field of pharmaceutical chemistry and fluorine chemistry and specifically discloses novel fluorine-containing 2,3-dihydrobenzofuran-3-alcohol and its preparation method. The specific preparation method is as follows: in a dry organic solvent, triphenyl phosphine difluoroacetate is used as a difluoromethylation reagent, and 2'-hydroxy chalcone with different substituent groups is transferred to a 2,2-difluoro-3-styryl-2,3-dihydrobenzofuran-3-alcoholic compound by one step. The fluorine-containing 2,3-dihydrobenzofuran alcohol is a compound with a wide range of application and especially has potential application value in the aspect of medicine.

Description

Fluorine-containing 2,3-Dihydrobenzofuranes-3-alcohol compound and preparation methods
Technical field
The present invention relates to pharmaceutical chemistry technology and fluorine chemistry field, disclose a kind of novel fluorine 2,3-Dihydrobenzofuranes-3-alcohol and preparation method thereof specifically.
Background technology
2,3-Dihydrobenzofuranes-3-alcohol be the important natural product skeleton of a class ( j. Med. Chem. 2011, 54, 3506; j. Nat. Prod. 2012, 75, 1500; j. Am. Chem. Soc. 2014, 136, 2659) and pharmaceutical chemicals skeleton (as anticarcinogen Silvestrol: j. Med. Chem. 2012, 55, 558; j. Med. Chem. 2012, 55, 8859; org. Lett. 2013, 15, 1406), develop the new compound containing 2,3-Dihydrobenzofuranes-3-ol skeleton and there is important medical practical value; The synthesis of this compounds generally need comparatively special raw material and metal catalyst ( j. Am. Chem. Soc. 2006, 128, 16504; j. Am. Chem. Soc. 2009, 131, 2786; angew. Chem. Int. Ed. 2012, 51, 971), therefore develop new nonmetal catalyzed method and prepare 2,3-Dihydrobenzofuranes-3-ol skeleton compound there is certain practical significance.
Fluorine (F)-as the highest element of electronegativity, be introduced in organic molecule, its physics, chemistry and biological physiology performance can be changed; It is determined by its special physiologically active that organic fluoride-containing compound is applied to pharmacy field; First, the radius of F is suitable with the radius of H, OH, and after H or OH in molecule is replaced by F, whole molecular volume and steric configuration change are not quite; Secondly, introduce the lipotropy that fluorine can strengthen organic molecule, fluorochemicals is strengthened the penetrativity of film, tissue in vivo, improve its absorption in vivo and transmission speed; Again, carbon-fluorine bond high stability, makes it be difficult to leave away with the form of ion or free radical, can cause the restraining effect to pathways metabolism in physiologically active; Therefore introduce in natural radioactivity molecule or pharmaceutical activity molecule fluorine be design new drug important method ( chem. Rev. 2014, 114, 2432; chem. Eur. J. 2014, 20, 16830); In fluorochemicals, containing difluoromethyl compound more and more come into one's own ( synthesis 2014, 46, 842).The bioisostere of difluoromethyl in hydroxyl, the hydroxyl in replaceable drug molecule and do not affect the pharmacological action of medicine; And utilize the strong lipotropy of difluoromethyl, the absorption of medicine can be promoted to reduce the consumption of medicine; Recently some medicine as: Desflurane (narcotic, drugs. 1995, 50, 742), Pantoprazole (gastric acid secretion inhibitor, drugs. 2003, 63, 101) and N-(difluoromethyl) pyridin-2 (1H)-one-substituted acetic acids (enzyme inhibitors, bioorg. Med. Chem. Lett. 2010, 20, 2168) all contain difluoromethyl group.
Difluoromethyl is introduced in 2,3-Dihydrobenzofuranes-3-ol skeleton compound, in conjunction with the advantage of two class groups, can will has important practical value in new drug design synthesis.
Summary of the invention
Object of the present invention is intended to expansion 2, the scope of 3-Dihydrobenzofuranes-3-alcohol, develops a kind of novel fluorine-containing 2,3-Dihydrobenzofuranes-3-alcohol compounds, another object of the present invention is to provide above-mentioned fluorine-containing 2,3-Dihydrobenzofuranes-3-alcohol compound preparation methods.
Fluorine-containing 2,3-Dihydrobenzofuranes-3-alcohol compounds of the present invention, is characterized in that it is the compound with following chemical structure of general formula:
In chemical general formula:
R 1for the substituted radical of phenyl ring, such as: the alkyl of H, halogen, methoxyl group, C1 ~ C6.
R 2for aromatic group, such as phenyl ring, containing substituent phenyl ring, containing substituent furans, containing substituent thiophene.
The preparation method of fluorine-containing 2,3-Dihydrobenzofuranes-3-alcohol compounds of the present invention, is characterized in that carrying out according to following step:
With different substituents 2 '-hydroxylated chalcone (formula I) and triphenylphosphine difluoroacetic acid salt ( chem. Commun. 2013, 49, 7513) and phase-transfer catalyst in dry organic solvent at 40 ~ 100 DEG C react 1 ~ 8 hour, boil off solvent, raffinate through silica gel column chromatography be separated obtain 2,2-bis-fluoro-3-styryl-2,3-Dihydrobenzofuranes-3-alcohol compound (formula II).
The mol ratio of described 2 '-hydroxylated chalcone and triphenylphosphine difluoroacetic acid salt and phase-transfer catalyst is 1: 1 ~ 3: 0 ~ 0.5.
Described organic solvent is: methylene dichloride, trichloromethane, tetracol phenixin, benzene, toluene, dimethylbenzene, p-Xylol, acetonitrile, tetrahydrofuran (THF), dimethyl formamide, N-Methyl pyrrolidone.
Described reaction solubility is that 0.1 ~ 1 mol/L(is as the criterion with 2 '-hydroxylated chalcone).
Described phase-transfer catalyst is: 4 bromide, tetraethylammonium bromide, Tetrabutyl amonium bromide, 18 hat six, 15 hats five.
The invention has the beneficial effects as follows and invented a kind of novel 2,2-bis-fluoro-3-styryl-2,3-Dihydrobenzofuranes-3-alcohol compounds, and obtain this compounds by easy method with good yield (the highest yield 75%).The compound of new synthesis, due to simultaneously containing 2,3-Dihydrobenzofuranes-3-ol skeleton and difluoromethyl group, therefore has potential using value at field of medicaments.
Embodiment
Contribute to understanding the present invention further by following example, but do not limit the present invention.
example 1: 2,2-bis-fluoro-3-styryl-2,3-Dihydro-benzofuran-3-alcohol
At room temperature, 112.1 milligrams of (0.5 mmol) 2 '-hydroxylated chalcones and 356.3 milligrams of (1.0 mmol) triphenylphosphine difluoroacetic acid salt are added in 100 milliliters of round-bottomed bottles, add the dry acetonitrile of 2 mL again, then oil bath is heated to 60 DEG C of reactions 2 hours; After being distilled out by solvent, mixture, through silica gel column chromatography, is eluent by ethyl acetate/petroleum ether (volume ratio 1/20), obtains 102.1 milligram of 2,2-bis-fluoro-3-styryl-2,3-Dihydro-benzofuran-3-alcohol, yield 75%.
1H NMR (400 MHz, CDCl 3) δ 2.92 (s, 1H), 6.39-6.44 (m, 1H), 6.92 (d, J =16.0 Hz, 1H), 7.06 (d, J =8.4 Hz, 1H), 7.17 (t, J = 7.2 Hz, 1H), 7.30-7.42 (m, 5H), 7.44-7.47 (m, 2H); 13C NMR (100 MHz, CDCl 3) δ 154.8, 135.7, 132.7, 131.6, 130.5 (t, J = 271.4 Hz), 128.7, 128.5, 127.8, 127.0, 125.2, 124.0, 111.1, 80.1-80.64 (m, 1C); 19F NMR (376 MHz, CDCl 3) δ-89.1(d, J = 142.9 Hz, 1F),-82.8(d, J = 142.9 Hz, 1F);MS (ESI) m/z 275.2 [M+H] +
example 2: the fluoro-3-of 2,2-bis-(4-vinyl toluene base)-2,3-Dihydro-benzofuran-3-alcohol
At room temperature, 119.1 milligrams of (0.5 mmol) 1-(2-hydroxy phenyl)-3-p-methylphenyl acrylketone and 356.3 milligrams of (1.0 mmol) triphenylphosphine difluoroacetic acid salt are added in 100 milliliters of round-bottomed bottles, then add 39.6 milligrams (0.15 mmol) 18 and be preced with six, add the dry acetonitrile of 5 mL again, then oil bath is heated to 80 DEG C of reactions 3 hours; After being distilled out by solvent, mixture, through silica gel column chromatography, is eluent by ethyl acetate/petroleum ether (volume ratio 1/20), obtains 63.2 milligram of 2,2-bis-fluoro-3-(4-vinyltoluene base)-2,3-Dihydro-benzofuran-3-alcohol, yield 46%.
1H NMR (400 MHz, CDCl3) δ2.35(s, 3H),3.00(s, 1H), 6.31-6.35 (dd, J = 16.0 Hz and J = 2.8 Hz, 1H), 6.85 (d, J = 16.0 Hz, 1H), 7.02 (d, J = 8.0 Hz, 1H), 7.11-7.16 (m, 3H), 7.32 (d, J = 8.0 Hz, 3H), 7.36-7.40 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 154.8, 138.4, 132.9, 132.5, 131.5, 130.5 (t, J = 271.6 Hz, 1C), 129.4, 128.4, 126.9, 125.3, 127.0, 125.3, 123.9, 123.0-123.1 (m, 1C), 111.0, 80.1-80.6 (m, 1C), 21.3; 19F NMR (376 MHz, CDCl3) δ-89.2(d, J = 142.9 Hz, 1F),-82.9(d, J = 142.5 Hz, 1F); MS (ESI) m/z 289.4 [M+H] +
example 3: the fluoro-3-of 2,2-bis-(4-methoxyl-styrene)-2,3-Dihydro-benzofuran-3-alcohol
The method similar with example 1 is synthesized, and solvent is acetonitrile, and 60 DEG C of reaction times are 8 hours, obtains 90.5 milligram of 2,2-bis-fluoro-3-(4-methoxyl-styrene)-2,3-Dihydro-benzofuran-3-alcohol, yield 59%.
1H NMR (400 MHz, CDCl 3) δ3.14(s, 1H),3.80(s, 3H), 6.23-6.27 (dd, J = 16.0 Hzand J = 2.8 Hz, 1H)6.79-6.87 (m, 3H), 7.01 (d, J = 8.0 Hz, 1H), 7.13 (t, J = 7.6 Hz, 1H), 7.31-7.39 (m, 4H); 13C NMR (100 MHz, CDCl 3) δ 159.8, 154.8, 132.1, 131.4, 130.6 (t, J = 271.1 Hz, 1C), 128.5, 128.4, 128.3, 125.3, 123.9, 121.8, 121.7, 114.1, 111.0, 80.1-80.6 (m, 1C), 55.3; 19F NMR (376 MHz, CDCl 3) δ-89.2(d, J = 142.9 Hz, 1F),-82.9(d, J = 142.5 Hz, 1F); MS (ESI) m/z 305.2 [M+H] +
example 4: the fluoro-3-of 2,2-bis-(4-fluorostyryl)-2,3-Dihydro-benzofuran-3-alcohol
The method similar with example 1 is synthesized, and solvent is dimethyl formamide, and 60 DEG C of reaction times are 1.5 hours, obtains 89.1 milligram of 2,2-bis-fluoro-3-(4-fluorostyryl)-2,3-Dihydro-benzofuran-3-alcohol, yield 61%.
1H NMR (400 MHz, CDCl 3) δ3.20(s, 1H), 6.27-6.32 (dd, J = 16.0 Hzand J = 2.8 Hz, 1H), 6.84 (d, J = 16.0 Hz, 1H), 7.00-7.04 (m, 3H), 7.11-7.15 (m, 1H), 7.30-7.32 (m, 1H), 7.36-7.40 (m, 3H); 13C NMR (100 MHz, CDCl 3) δ 164.0, 161.6, 154.7, 133.2, 131.9, 131.6, 131.5, 130.5 (t, J = 272.1 Hz, 1C), 128.7, 128.6, 128.6, 128.2, 125.2, 124.0, 120.7, 116.3(t, J = 259.2 Hz, 1C), 19F NMR (376 MHz, CDCl 3) δ-113.2(s,1F),-89.0(d, J = 142.9 Hz, 1F),-82.8(d, J = 142.5 Hz, 1F); 116.0; MS (ESI) m/z 293.2 [M+H] +
example 5: the fluoro-3-of 2,2-bis-(4-chloro-styrene base)-2,3-Dihydro-benzofuran-3-alcohol
The method similar with example 1 is synthesized, and solvent is N-Methyl pyrrolidone, and 40 DEG C of reaction times are 4 hours, obtains 83.4 milligram of 2,2-bis-fluoro-3-(4-chloro-styrene base)-2,3-Dihydro-benzofuran-3-alcohol, yield 54%.
1H NMR (400 MHz, CDCl 3) δ 3.45 (s, 1H), 6.32-6.37 (dd, J = 16.0 Hzand J = 2.8 Hz, 1H), 6.84 (d, J = 16.0 Hz, 1H), 7.01 (d, J = 8.0 Hz, 1H), 7.11-7.15 (m, 1H),-7.28-7.40 (m, 6H); 13C NMR (100 MHz, CDCl 3) δ 154.7, 134.3, 134.1, 131.6,131.4, 130.5 (t, J = 272.3 Hz, 1C), 128.9, 128.2, 125.3, 124.9, 124.0, 111.1,80.0-80.5 (m, 1C); 19F NMR (376 MHz, CDCl 3) δ-88.6(d, J = 142.9 Hz, 1F),-82.5(d, J = 142.5 Hz, 1F); MS (ESI) m/z 309.1 [M+H] +
example 6: the fluoro-3-of 2,2-bis-(2-bromstyrol base)-2,3-Dihydro-benzofuran-3-alcohol
The method similar with example 2 is synthesized, and catalyzer is Tetrabutyl amonium bromide, and solvent is tetrahydrofuran (THF), and 60 DEG C of reaction times are 2 hours, obtains 125.4 milligram of 2,2-bis-fluoro-3-(2-bromstyrol base)-2,3-Dihydro-benzofuran-3-alcohol, yield 71%.
1H NMR (400 MHz, CDCl 3) δ 3.20 (s, 1H), 6.29-6.34 (dd, J = 16.0 Hzand J = 2.8 Hz, 1H), 7.02 (d, J = 8.0 Hz, 1H), 7.12-7.16 (m, 2H),-7.24-7.30 (m, 2H), 7.35-7.41 (m, 2H), 7.52-7.58 (m, 2H); 13C NMR (100 MHz, CDCl 3) δ 135.9, 133.0, 131.7, 133.1, 131.6, 129.6 (t, J = 270.9 Hz, 1C),128.0, 127.6, 127.5, 127.2, 127.1, 125.3, 124.1, 124.0, 111.0; 19F NMR (376 MHz, CDCl 3) δ -89.0(d, J = 142.9 Hz, 1F),-82.5(d, J = 142.9 Hz, 1F); MS (ESI) m/z 309.1 [M+H] +
example 7: the fluoro-3-of 2,2-bis-(3-phenoxy group styryl)-2,3-Dihydro-benzofuran-3-alcohol
The method similar with example 1 is synthesized, and solvent is acetonitrile, and 60 DEG C of reaction times are 3 hours, obtains 62.3 milligram of 2,2-bis-fluoro-3-(3-phenoxy group styryl)-2,3-Dihydro-benzofuran-3-alcohol, yield 34%.
1H NMR (400 MHz, CDCl 3) δ 3.20 (s, 1H), 6.33-6.38 (dd, J = 16.0 Hzand J = 2.8 Hz, 1H), 6.85 (d, J = 16.0 Hz, 1H), 6.93-6.95 (m, 1H), 7.01-7.03 (m, 3H), 7.08-7.15 (m, 3H), 7.17-7.19 (m, 1H), 7.26-7.40 (m, 5H); 13C NMR (100 MHz, CDCl 3) δ 157.6, 157.1, 154.7, 137.6, 132.0, 131.6, 130.5 (t, J = 271.7 Hz, 1C), 130.0, 129.8, 128.2, 125.3, 125.0, 124.9, 124.0, 123.5, 123.4, 122.0, 118.9, 118.8, 117.4, 111.1, 80.0-80.5 (m, 1C); 19F NMR (376 MHz, CDCl 3) δ-88.8(d, J = 142.9 Hz, 1F),-82.7(d, J = 142.9 Hz, 1F); MS (ESI) m/z 309.1 [M+H] +
example 8: the fluoro-3-of 2,2-bis-(3-methyl-2-thiofuran ethylene base)-2,3-Dihydro-benzofuran-3-alcohol
The method similar with example 2 is synthesized, and solvent is acetonitrile, and 60 DEG C of reaction times are 1 hour, obtains 64.8 milligram of 2,2-bis-fluoro-3-(3-methyl-2-thiofuran ethylene base)-2,3-Dihydro-benzofuran-3-alcohol, yield 44%.
1H NMR (400 MHz, CDCl 3) δ 2.26 (s, 3H), 6.09-6.14 (dd, J = 16.0 Hzand J = 2.8 Hz, 1H), 6.81 (d, J = 5.2 Hz, 1H),-7.01-7.15 (m, 4H),-7.31-7.33 (m, 1H), 7.36-7.40 (m, 1H); 13C NMR (100 MHz, CDCl 3) δ 154.8, 154.7, 136.8, 134.4, 133.1, 131.6, 130.7, 130.4 (t, J = 271.3 Hz, 1C), 128.4, 125.2, 124.2, 124.0, 122.5, 122.4, 111.0, 14.0; 19F NMR (376 MHz, CDCl 3) δ-89.7 (d, J = 142.9 Hz, 1F),-82.5(d, J = 143.6 Hz, 1F);MS (ESI) m/z 295.2 [M+H] +
example 9: the fluoro-3-of 2,2-bis-(2-(5-methyl-2-furans vinyl)-2,3-Dihydro-benzofuran-3-alcohol
The method similar with example 1 is synthesized, and solvent is p-Xylol, and 60 DEG C of reaction times are 1 hour, obtains 39.1 milligram of 2,2-bis-fluoro-3-(2-(5-methyl-2-furans vinyl)-2,3-Dihydro-benzofuran-3-alcohol, yield 28%.
1H NMR (400 MHz, CDCl 3) δ 2.30 (s, 3H), 2.94 (s, 1H), 5.98-5.99 (m, 1H), 6.21-6.25 (m, 2H), 6.62 (d, J = 15.6 Hz, 1H), 7.00 (d, J = 8.0 Hz, 1H), 7.09-7.13 (m, 1H), 7.26-7.38 (m, 2H); 13C NMR (100 MHz, CDCl 3) δ 154.7, 153.0, 150.0, 131.4, 130.5 (t, J = 271.8 Hz, 1C), 128.4, 125.2, 123.9, 120.9, 120.7 (d, J = 5.0 Hz, 1C), 111.2, 111.0, 107.7, 80.0-80.5 (m, 1C),13.7; MS (ESI) m/z 279.2 [M + H] +; 19F NMR (376 MHz, CDCl 3) δ-89.3 (d, J = 142.5 Hz, 1F),-83.0 (d, J = 142.5 Hz, 1F); IR (KBr) ν 3027, 2963, 2923, 2853, 1756, 1716, 1679, 1619, 1596, 1465, 1367, 1322, 1261, 1098, 1072, 1021, 932, 871, 799, 750, 617 cm -1.
example 10: 2,2,5-tri-fluoro-3-styryl-2,3-Dihydro-benzofuran-3-alcohol
The method similar with example 1 is synthesized, and solvent is acetonitrile, and 60 DEG C of reaction times are 2 hours, obtains 64.7 milligram of 2,2,5-tri-fluoro-3-styryl-2,3-Dihydro-benzofuran-3-alcohol, yield 44%.
1H NMR (400 MHz, CDCl 3) δ 3.28 (s, 1H), 6.33-6.38 (dd, J = 8.0 Hzand J = 2.8 Hz, 1H), 6.89 (d, J = 16.0 Hz, 1H), 6.96-6.99 (dd, J = 16.0 Hzand J = 16.0 Hz, 1H),7.02-7.10 (m, 2H), 7.30-7.38 (m, 3H), 7.43-7.45 (m, 2H); 13C NMR (100 MHz, CDCl 3) δ 160.3, 157.9, 150.5, 135.4, 132.9, 130.7 (t, J = 271.3 Hz, 1C), 129.7, 129.6, 128.9, 128.8, 128.6, 128.0, 127.0, 123.5, 123.4, 118.3, 118.1, 112.5, 112.3, 112.1, 112.0, 80.8, 80.6, 80.5, 80.3; 19F NMR (376 MHz, CDCl 3) δ -117.9(s, 1F),-88.3(d, J = 141.8 Hz, 1F),-82.7(d, J = 142.1 Hz, 1F); MS (ESI) m/z 293.2 [M+H] +
example 11: 2,2,6-tri-fluoro-3-styryl-2,3-Dihydro-benzofuran-3-alcohol
The method similar with example 1 is synthesized, and solvent is tetracol phenixin, and 60 DEG C of reaction times are 2 hours, obtains 48.2 milligram of 2,2,6-tri-fluoro-3-styryl-2,3-Dihydro-benzofuran-3-alcohol, yield 33%.
1H NMR (400 MHz, CDCl 3) δ 4.22 (s, 1H), 6.37-6.41 (dd, J = J = 16.0 Hzand 2.4 Hz, 1H), 6.74-6.77 (m, 1H),6.81-6.93 (m, 2H), 7.26-7.38 (m, 4H), 7.44 (d, J = 32.0 Hz, 2H), 7.43-7.45 (m, 2H) ; 13C NMR (100 MHz, CDCl 3) δ 165.8, 163.3, 163.1, 155.7, 155.5, 135.7, 132.8, 130.8 (t, J = 273.1 Hz, 1C), 128.8, 128.6, 127.2, 127.0, 126.7, 126.6, 126.5, 124.2, 124.1, 111.1, 110.9, 99.9, 99.6, 80.1, 79.8, 79.7, 79.6; 19F NMR (376 MHz, CDCl 3)δ-107.1(s, 1F),-88.3(d, J = 141.4 Hz, 1F),-81.3(d, J = 141.0 Hz, 1F); MS (ESI) m/z 293.2 [M+H] +
example 12: bromo-2,2-bis-fluoro-3-styryl-2, the 3-Dihydro-benzofuran-3-alcohol of 5,7-bis-
The method similar with example 1 is synthesized, and solvent is dimethylbenzene, and 100 DEG C of reaction times are 1 hour, obtains 129.6 milligram of 5,7-bis-bromo-2,2-bis-fluoro-3-styryl-2,3-Dihydro-benzofuran-3-alcohol, yield 60%.
1H NMR (400 MHz, CDCl 3) δ 3.22 (s, 1H), 6.31-6.35 (dd, J = 16.0 Hzand J = 2.4 Hz, 1H), 6.93 (d, J = 16.0 Hz, 1H), 7.32-7.38 (m, 4H), 7.43-7.45 (m, 2H), 7.68 (d, J = 2.0 Hz, 2H); 13C NMR (100 MHz, CDCl 3) δ 151.5, 136.8, 135.2, 133.7, 133.4, 131.2 (t, J = 125.4 Hz, 1C), 128.8, 127.3, 127.2, 127.1, 122.7, 127.0, 122.6, 116.5, 104.8; 19F NMR (376 MHz, CDCl 3) δ-88.2(d, J = 140.6 Hz, 1F),-82.2(d, J = 140.6 Hz, 1F);MS (ESI) m/z 432.8 [M] +
The present invention is not limited to the technology described in embodiment; its description is illustrative; and it is nonrestrictive; authority of the present invention limited by claim; can change according to the present invention based on the art personnel, technology related to the present invention that the method such as restructuring obtains, all within protection scope of the present invention.

Claims (7)

1. fluorine-containing 2,3-Dihydrobenzofuranes-3-alcohol compounds, is characterized in that the chemical structure of general formula of described compound is:
In chemical general formula:
R 1for the substituted radical of phenyl ring, it is the alkyl of H, halogen, methoxyl group or C1 ~ C6;
R 2for aromatic group.
2. fluorine-containing 2,3-Dihydrobenzofuranes-3-alcohol compounds as claimed in claim 1, is characterized in that: described aromatic group is phenyl ring, containing substituent phenyl ring, containing substituent furans or containing substituent thiophene.
3. the preparation method of fluorine-containing 2,3-Dihydrobenzofuranes-3-alcohol compounds as claimed in claim 1, is characterized in that: carry out according to following step:
In dry organic solvent, at 40 ~ 100 DEG C, 1 ~ 8 hour is reacted with 2 '-hydroxylated chalcone of different substituents and triphenylphosphine difluoroacetic acid salt and phase-transfer catalyst, boil off solvent, raffinate is separated through silica gel column chromatography and obtains 2,2-bis-fluoro-3-styryl-2,3-Dihydrobenzofuranes-3-alcohol compound.
4. as claimed in claim 3 fluorine-containing 2, the preparation method of 3-Dihydrobenzofuranes-3-alcohol compound, is characterized in that: the mol ratio of described 2 '-hydroxylated chalcone and triphenylphosphine difluoroacetic acid salt and phase-transfer catalyst is 1: 1 ~ 3: 0 ~ 0.5.
5. as claimed in claim 3 fluorine-containing 2, the preparation method of 3-Dihydrobenzofuranes-3-alcohol compound, is characterized in that: described organic solvent is: methylene dichloride, trichloromethane, tetracol phenixin, benzene, toluene, dimethylbenzene, p-Xylol, acetonitrile, tetrahydrofuran (THF), dimethyl formamide or N-Methyl pyrrolidone.
6. the preparation method of fluorine-containing 2,3-Dihydrobenzofuranes-3-alcohol compounds as claimed in claim 3, is characterized in that: the reaction solubility of described 2 '-hydroxylated chalcone is 0.1 ~ 1 mol/L.
7. the preparation method of fluorine-containing 2,3-Dihydrobenzofuranes-3-alcohol compounds as claimed in claim 3, is characterized in that described phase-transfer catalyst is: 4 bromide, tetraethylammonium bromide, Tetrabutyl amonium bromide, 18 hat six or 15 hats five.
CN201510171596.6A 2015-04-13 2015-04-13 The fluorine-containing alcohol compound of 2,3 Dihydrobenzofuranes 3 and preparation method Active CN104817525B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510171596.6A CN104817525B (en) 2015-04-13 2015-04-13 The fluorine-containing alcohol compound of 2,3 Dihydrobenzofuranes 3 and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510171596.6A CN104817525B (en) 2015-04-13 2015-04-13 The fluorine-containing alcohol compound of 2,3 Dihydrobenzofuranes 3 and preparation method

Publications (2)

Publication Number Publication Date
CN104817525A true CN104817525A (en) 2015-08-05
CN104817525B CN104817525B (en) 2017-11-17

Family

ID=53728026

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510171596.6A Active CN104817525B (en) 2015-04-13 2015-04-13 The fluorine-containing alcohol compound of 2,3 Dihydrobenzofuranes 3 and preparation method

Country Status (1)

Country Link
CN (1) CN104817525B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109867645A (en) * 2017-12-05 2019-06-11 中国医学科学院药物研究所 A kind of synthetic method of 2,2- bis- fluoro- 2,3- dihydro substitution benzofuran compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014144037A1 (en) * 2013-03-15 2014-09-18 Bristol-Myers Squibb Company Lxr modulators

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014144037A1 (en) * 2013-03-15 2014-09-18 Bristol-Myers Squibb Company Lxr modulators

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JIAN ZHENG ET AL.: "Synthesis and decarboxylative Wittig reaction of difluoromethylene phosphobetaine", 《CHEM. COMMUN.》 *
张留印等: "5-氟-2,3-二氢苯并呋喃的合成", 《中国医药工业杂志》 *
金晓董等: "3-(2,3-二氢苯并呋喃-5-基)丙酸合成工艺的改进", 《华西药学杂志》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109867645A (en) * 2017-12-05 2019-06-11 中国医学科学院药物研究所 A kind of synthetic method of 2,2- bis- fluoro- 2,3- dihydro substitution benzofuran compounds
CN109867645B (en) * 2017-12-05 2021-09-14 中国医学科学院药物研究所 Synthetic method of 2, 2-difluoro-2, 3-dihydro-substituted benzofuran compound

Also Published As

Publication number Publication date
CN104817525B (en) 2017-11-17

Similar Documents

Publication Publication Date Title
CN106565648B (en) The synthetic method of fluorine-containing alkyl-substituted 2,3- dihydro-benzofuran derivative and indole derivatives
CN105801575B (en) A kind of synthetic method of imidazo [1,2-a] pyridine
Schwalm et al. Metal halide hydrates as lewis acid catalysts for the conjugated friedel-crafts reactions of indoles and activated olefins
CN112390804B (en) Cyclopentachromanone spliced spiro-oxoindole compound and preparation method and application thereof
CN104817525A (en) Fluorine-containing 2,3-dihydrobenzofuran-3-alcoholic compound and preparation method thereof
CN110845466B (en) Oxacyclonadiene derivatives, pharmaceutical compositions thereof, process for their preparation and their use
CN104829465A (en) Method for preparing 4-isopropamide group-1-butanol
CN108911937B (en) Synthesis method of tetraarylethylene compound
CN106543095B (en) A method of benzo isoxazole is prepared based on 2- hydroxy acetophenone oxime and its one pot of derivative
CN103113174B (en) Preparation method of phenolic compounds
CN115010753A (en) Method for preparing phosphorylated gem-difluorodiene compound in aqueous phase
CN101891636A (en) Novel method for preparing esmolol hydrochloride optical isomer
CN102557943B (en) Method for synthesizing aromatic formic acid aryl ester derivative
CN101693642B (en) Method for synthesizing 1,2-diphenylethylene compounds
CN107417604A (en) Benzamide compound of 4 substituted pyridines 2 and preparation method and application
CN110698426A (en) Method for preparing 1, 3-benzothiazole derivative by efficient catalysis of potassium tert-butoxide
CN106117203B (en) A kind of synthetic method of 3 arylthio Imidazoheterocyclic compounds
JP6057257B2 (en) Method for producing optically active carboxylic acid ester
CN105622544B (en) A kind of synthetic method of N- sulfonyls -3,4- dihydro -2H-1,4- thiazines
CN110172015A (en) α-quaternary carbon trifluoromethyl ketone compound and preparation method thereof
CN110590621B (en) Method for synthesizing 1, 2-bis (arylsulfonyl) ethylene derivative by copper-catalyzed terminal alkyne
CN111302930B (en) Preparation method of p-phenylbutoxy benzoic acid
CN107827789A (en) A kind of method of copper catalysis synthesis of phenyl benzyl compound
CN102826985B (en) A kind of preparation method of 1-(3,4,5-trihydroxy-) phenyl-1-alkyl ketone
CN102675204B (en) Intermediate for synthesizing (I)-huperzine A, synthesis method and usage thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant